A food or nutritional or dietary composition or food or nutritional or dietary supplement suited for buccal delivery of cannabinoids comprises a source of cannabinoids in combination with a vasodilator agent selected from essentials oils or components of same, flavors or components of same and spices or components of same. Preferred source of cannabinoids is standardized oil or extract of hemp (Cannabis sativa L.).

A herbal composition for treatment of digestive system related diseases comprising,

TABLE-US-00001 1) Foeniculum vulgare 50.47% to 85.43% 2) Trachyspemum ammi 29.93% to 9.75% 3) Dolichandrone falcata 0.20% to 0.02% 4) Morinda citrifolia 0.20% to 0.05% 5) Syzygium aromatic 3.90% to 0.75% 6) Piper nigrum 3.90% to 0.50% 7) Cinnamomum zeylanicum 3.90% to 1.00% 8) Black salt 2.10% to 1.00% 9) Sodium bicarbonate 1.50% to 0.50% 10) IIIilcium verum 3.90% to 1.00%

A herbal composition for treatment of digestive system related diseases comprising,

TABLE-US-00001 1) Foeniculum vulgare 50.47% to 85.43% 2) Trachyspemum ammi 29.93% to 9.75% 3) Dolichandrone falcata 0.20% to 0.02% 4) Morinda citrifolia 0.20% to 0.05% 5) Syzygium aromatic 3.90% to 0.75% 6) Piper nigrum 3.90% to 0.50% 7) Cinnamomum zeylanicum 3.90% to 1.00% 8) Black salt 2.10% to 1.00% 9) Sodium bicarbonate 1.50% to 0.50% 10) IIIilcium verum 3.90% to 1.00%

A herbal composition for treatment of digestive system related diseases comprising,

TABLE-US-00001 1) Foeniculum vulgare 50.47% to 85.43% 2) Trachyspemum ammi 29.93% to 9.75% 3) Dolichandrone falcata 0.20% to 0.02% 4) Morinda citrifolia 0.20% to 0.05% 5) Syzygium aromatic 3.90% to 0.75% 6) Piper nigrum 3.90% to 0.50% 7) Cinnamomum zeylanicum 3.90% to 1.00% 8) Black salt 2.10% to 1.00% 9) Sodium bicarbonate 1.50% to 0.50% 10) IIIilcium verum 3.90% to 1.00%

In preferred embodiments the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil.

In preferred embodiments the invention is directed to ocular compositions for the treatment of dry eye, methods for making such compositions, and suites comprising a plurality of different ocular compositions each having a defined composition. In preferred examples, the invention is directed to compositions comprising at least one natural oil, wherein a first member of the suite of compositions is effective in treating dry in in a first patient having a particular set of symptoms and a different second member of the suite of compositions is effective in treating dry in in a second patient having a different set of symptoms. The invention is also directed to methods of making and using the compositions, and to skin care compositions for use around the eye, such as the upper and lower eyelids having a lubricating, non-irritating base composition comprising at least one natural oil.

A liquid composition comprising: a primary component being an Active Pharmaceutical Ingredient (API), a nutritional supplement, or combinations thereof: a base; and a preservative blend is provided along with a method of making said composition.

A liquid composition comprising: a primary component being an Active Pharmaceutical Ingredient (API), a nutritional supplement, or combinations thereof: a base; and a preservative blend is provided along with a method of making said composition.

A liquid composition comprising: a primary component being an Active Pharmaceutical Ingredient (API), a nutritional supplement, or combinations thereof: a base; and a preservative blend is provided along with a method of making said composition.

A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.